Brind.

Alfred W. Sandrock, Jr. was appointed as the Chief Executive Officer of Voyager Therapeutics on August 7, 2025.

2 reports, 2 independent Updated Oct 21
Gone quiet
Reports
2
Developments
2
Repetition
0%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Alfred W. Sandrock, Jr. was appointed as the Chief Executive Officer of Voyager Therapeutics on August 7, 2025.

Who's involved

What this event is mainly about
Voyager Therapeutics (United States)

How it developed

Newest first. Tap a step to see who reported it.
  1. Swartz appointed President of Voyager and expected to succeed Sandrock as CEO.1 source
  2. Alfred W. Sandrock, Jr. became the CEO of Voyager Therapeutics.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • manilatimes.net
  • GlobeNewswireVoyager Reports Second Quarter 2025 Financial and Operating Results - Cash runway extended into 2028; expected to enable multiple meaningful clinical data read-outs - - APOE program added to pipeline